| Preface | 6 |
---|
| Contents | 9 |
---|
| Contributors | 10 |
---|
| 1 Introduction | 12 |
---|
| 2 Horizontal Gene Transfers with or without Cell Fusions in All Categories of the Living Matter | 15 |
---|
| 2.1 Acquisition and Horizontal Transfer of Vibrio cholerae Virulence Gene | 15 |
| 2.1.1 Hamburg 1892 | 15 |
| 2.1.2 The Vibrio and the Disease | 16 |
| 2.1.3 The Phage and Its Genome | 19 |
| 2.1.4 The Hiding Place of the Original Cholera Virulence Genes | 21 |
| 2.2 Mimivirus and Its Companions | 23 |
| 2.2.1 Viruses and Toxins of Blooming Dinoflagellates | 23 |
| 2.2.2 Genes of the Mimivirus Shared with Its Phage and with Its Host Amoeba | 26 |
| 2.3 Interviral (Virus-to-Virus) Gene Transfers | 29 |
| 2.3.1 Marek's Disease Herpesvirus | 29 |
| 2.3.2 Reticuloendotheliosis Virus Genomic Sequences in the Marek's Virus and in the Fowlpox Virus Genomes | 29 |
| 2.3.3 Herpesviruses Activate Latent Retroviruses | 32 |
| 2.3.4 Avian Herpesviruses Descend from Theropod Dinosaurs? | 32 |
| 2.4 Horizontal Gene Transfers in Archaea and Prokaryota | 36 |
| 2.4.1 The Darwinian Threshold (Woese) | 36 |
| 2.4.2 The Ancient Origin of ''Virulence Genes'' | 39 |
| 2.4.3 A Selected Example of Speciation | 41 |
| 2.5 The Insertion of Adaptive Immunity Genes | 44 |
| 2.5.1 Retrotransposons | 44 |
| 2.5.2 An Ancient Herpesvirus | 47 |
| 2.6 Horizontal Gene Gains in Eukaryota | 49 |
| 2.6.1 Viral Genes | 49 |
| 2.6.1.1 Bornavirus in Human Brain Cells | 49 |
| 2.6.1.2 Human Herpesvirus-6 in Human Telomers | 51 |
| 2.6.2 Horizontal Gene Transfers in Eukaryota | 52 |
| 2.7 Epithelial-to-Mesenchymal Transition of Human Cancer Cells | 58 |
| 2.7.1 Bacteria Inducing Inflammatory Cancers | 58 |
| 2.7.1.1 Helicobacter Pylori: Cancers of the Soil and Seed | 58 |
| 2.7.1.2 Bacteroides Fragilis: Inflammatory Carcinogenesis with or Without It | 59 |
| 2.7.2 The Epithelial-to-Mesenchymal Transformation | 64 |
| 2.8 Horizontal Transfer of Proto-Oncogenes | 66 |
| 2.9 Horizontal Gene Transfers for the Treatment and Cure of Cancer | 67 |
| 2.10 Consequences | 68 |
| 2.11 Summary | 69 |
| References | 70 |
| 3 Class III Viral Membrane Fusion Proteins | 100 |
---|
| 3.1 Introduction | 100 |
| 3.1.1 Definition of Class III Fusion Proteins | 100 |
| 3.1.2 Viruses Encoding Class III Fusion Proteins | 101 |
| 3.1.3 The Multiple Roles of Class III Fusion Proteins | 101 |
| 3.2 Structural Features of Class III Viral Fusion Proteins | 102 |
| 3.2.1 Global Structural Organization of Class III Fusion Proteins | 102 |
| 3.2.2 Domain Organization of Class III Fusion Proteins | 103 |
| 3.3 Functionally Important Regions of Class III Fusion Proteins | 104 |
| 3.3.1 Fusion Loops | 104 |
| 3.3.2 Membrane-Proximal (Stem) Regions and C-Terminal Domain (CTD) | 105 |
| 3.4 Molecular Basis of the Class III Type Proteins Fusion Mechanism | 106 |
| 3.4.1 Activation Triggers for Class III Viral Fusogens | 106 |
| 3.4.2 Structural Rearrangements of Class III Fusion Proteins | 106 |
| References | 107 |
| 4 Human Trophoblast in Trisomy 21: A Model for Cell--Cell Fusion Dynamic Investigation | 111 |
---|
| 4.1 Human Placenta and Trophoblast Differentiation | 111 |
| 4.2 Membranes Proteins Involved in Human Trophoblast Fusion and Differentiation | 112 |
| 4.2.1 Syncytin-1 | 114 |
| 4.2.2 Syncytin-2 | 114 |
| 4.2.3 Syncytin-1 and Syncytin-2 Expression During In Vitro Trophoblast Differentiation | 115 |
| 4.3 Abnormal Trophoblast Fusion and Differentiation in Trisomy 21 | 115 |
| 4.4 CellCell Fusion: A Dynamic Process | 116 |
| 4.5 In Vitro Reversibility of Abnormal Trophoblast Fusion and Differentiation in T21 | 116 |
| References | 118 |
| 5 Cell Fusion and Hyperactive Osteoclastogenesis in Multiple Myeloma | 121 |
---|
| 5.1 Introduction | 121 |
| 5.2 Cell Fusion in Multiple Myeloma | 122 |
| 5.2.1 Ploidy Abnormalities | 123 |
| 5.2.2 Centrosome Amplification | 123 |
| 5.2.3 Myeloma Stem Cells | 124 |
| 5.2.4 Macrophage Fusion and Metastatic Potential of Malignant Plasma Cells | 125 |
| 5.2.5 Upregulated Osteoclastogenesis | 126 |
| 5.3 The Origin and Role of the Osteoclasts in MM | 126 |
| 5.3.1 Enhanced Marrow Levels of Osteoclastogenic Factors | 126 |
| 5.3.2 Osteoclast-Like Myeloma Polykaryons | 127 |
| 5.3.3 Osteoclast-Myeloma Hybrids | 129 |
| 5.4 New Evidence of Cell Fusion in MM | 130 |
| 5.4.1 Increased Expression of Fusogenic Proteins | 130 |
| 5.4.2 Osteoclast Transdifferentiation of Dendritic Cells | 130 |
| 5.4.3 Functional Osteoclast-Like Activity of Malignant Plasma Cells | 132 |
| 5.5 Conclusion | 133 |
| References | 133 |
| 6 Cell Fusion Hypothesis of the Cancer Stem Cell | 137 |
---|
| 6.1 Introduction | 137 |
| 6.2 Cell Fusion: A Hidden Force in Cancer Progression | 138 |
| 6.3 CSCs: A Conceptual Advance in Cancer Biology | 139 |
| 6.4 The Cell Fusion Hypothesis of CSCs | 141 |
| 6.5 Conclusions | 144 |
| References | 144 |
| 7 Expression of Macrophage Antigens by Tumor Cells | 149 |
---|
| 7.1 Introduction | 149 |
| 7.2 Macrophage Antigen CD14 | 150 |
| 7.3 Macrophage Antigen CD68 | 151 |
| 7.4 Macrophage Antigen MAC387 | 151 |
| 7.5 Macrophage Antigen CD163 | 151 |
| 7.6 CD163 Expression in Breast Cancer | 153 |
| 7.7 CD163 Expression in Colorectal Cancer
|